WallStreetZenWallStreetZen

NASDAQ: EDIT
Editas Medicine Inc Stock Ownership - Who owns Editas Medicine?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Editas Medicine Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amy ParisonSVP Chief Financial Officer2026-06-03464$2.70
$1.25kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2026-06-03731$2.70
$1.97kSell
Gilmore Neil OneillCEO2026-06-0315,380$2.70
$41.54kSell
Gilmore Neil OneillCEO2026-03-035,394$2.02
$10.90kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2026-03-03749$2.02
$1.51kSell
Amy ParisonSVP Chief Financial Officer2026-03-03474$2.02
$957.48Sell
Amy ParisonSVP Chief Financial Officer2025-12-03461$2.15
$992.53Sell
Gilmore Neil OneillCEO2025-12-035,603$2.15
$12.06kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2025-12-03713$2.15
$1.54kSell
Gilmore Neil OneillCEO2025-09-035,592$2.60
$14.52kSell

1 of 2

EDIT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EDIT insiders and whales buy or sell their stock.

EDIT Shareholders

What type of owners hold Editas Medicine Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.46%9,263,312$24.92MInstitution
Vanguard Capital Management LLC4.29%4,204,369$11.31MInstitution
Renaissance Technologies LLC4.06%3,972,160$10.69MInstitution
Kevin P. Starr3.99%3,906,176$10.51MInsider
Third Rock Ventures III LP3.99%3,906,176$10.51MInsider
Polaris Venture Management Co VI LLC3.88%3,797,144$10.21MInsider
Vanguard Portfolio Management LLC3.22%3,148,570$8.47MInstitution
Viking Global Investors LP3.06%2,996,590$8.06MInsider
Kevin Bitterman2.86%2,797,144$7.52MInsider
Flagship Ventures Fund IV LP2.85%2,786,967$7.50MInsider

1 of 3

EDIT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EDIT52.94%33.64%Net SellingNet Selling
ZNTL58.13%41.87%Net Selling
MGNX64.20%35.80%Net Buying
ARMP4.57%95.43%Net Selling
SRZN34.48%65.52%Net BuyingNet Buying
View Top Biotech Stocks

Editas Medicine Stock Ownership FAQ

Who owns Editas Medicine?

Editas Medicine (NASDAQ: EDIT) is owned by 52.94% institutional shareholders, 33.64% Editas Medicine insiders, and 13.42% retail investors. Kevin P. Starr is the largest individual Editas Medicine shareholder, owning 3.91M shares representing 3.99% of the company. Kevin P. Starr's Editas Medicine shares are currently valued at $10.51M.

If you're new to stock investing, here's how to buy Editas Medicine stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.